SM Pharmco Limited

	Page
Balance Sheet	1—2
Notes to the Financial Statements	3—4

Registered number: 14830299

		2025		2024
	Notes	£	£	£	£
FIXED ASSETS
Investments	4		201,002		201,002

			201,002		201,002
CURRENT ASSETS
Debtors	5	-		49,903
Cash at bank and in hand		155,762		109,732

		155,762		159,635
Creditors: Amounts Falling Due Within One Year	6	(357,018 )		(360,635 )

NET CURRENT ASSETS (LIABILITIES)			(201,256 )		(201,000 )

TOTAL ASSETS LESS CURRENT LIABILITIES			(254 )		2

NET (LIABILITIES)/ASSETS			(254 )		2

CAPITAL AND RESERVES
Called up share capital	7		2		2
Profit and Loss Account			(256 )		-

SHAREHOLDERS' FUNDS			(254)		2

Page 1

Page 2

SM Pharmco Limited

Balance Sheet (continued)

As At 31 August 2025

For the year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.

On behalf of the board

Mr Muhammad Javed

Director

19/03/2026

The notes on pages 3 to 4 form part of these financial statements.

1. General Information

SM Pharmco Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14830299 . The registered office is Office 1, 21 Hatherton Street, Walsall, England, WS4 2LA.

2. Accounting Policies

2.1. Basis of Preparation of Financial Statements

The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

2.2. Going Concern Disclosure

The directors have not identified any material uncertainties related to events or conditions that may cast significant doubt about the company's ability to continue as a going concern.

3. Average Number of Employees

Average number of employees, including directors, during the year was: 2 (2024: 2)

4. Investments

	Unlisted
	£
Cost or Valuation
As at 1 September 2024	201,002

As at 31 August 2025	201,002

Provision
As at 1 September 2024	-

As at 31 August 2025	-

Net Book Value
As at 31 August 2025	201,002

As at 1 September 2024	201,002

5. Debtors

	2025	2024
	£	£
Due within one year
Other debtors	-	49,903

Page 3

Page 4

SM Pharmco Limited

Notes to the Financial Statements (continued)

For The Year Ended 31 August 2025

6. Creditors: Amounts Falling Due Within One Year

	2025	2024
	£	£
Other creditors	357,018	360,635

7. Share Capital

	2025	2024
Allotted, called up and fully paid	£	£
2 Ordinary Shares of £ 1.00 each	2	2

8. Related Party Transactions

Included in other creditors are the balance due to the companies mentioned below as at 31 August 2025:

LP SD Ninety Nine Limited - £28,249 (2024 - £27,203)

LP SD Eighty Five Limited - £1,082 (2024 - £22,699)

Above loans are interest free and repayable on demand.

Mr Muhammad Tayyab Javed and Mr Sach Kartar Singh Sembhi are the directors of above mentioned companies as at 31 August 2025.

Page 4